KETO PATENT GROUP INC has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are HERMANN LARS HOLGER, RUBICON RES PVT LTD and EPI HEALTH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Mexico | 2 | |
#7 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Wilson Jacob | 15 |
#2 | Lacore Terry | 15 |
#3 | Lowery Ryan | 15 |
#4 | Wells Shawn | 13 |
#5 | Underwood Brian | 11 |
#6 | Harding Christopher N | 5 |
#7 | Harding Chistopher N | 4 |
#8 | Terry Lacore | 2 |
#9 | Brian Underwood | 2 |
#10 | Ryan Lowery | 2 |
Publication | Filing date | Title |
---|---|---|
US2020129463A1 | Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans | |
US2019255028A1 | Administration of berberine metabolites | |
AU2017253110A1 | Administration of berberine metabolites | |
MX2018012799A | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans. | |
CA3021784A1 | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |